Literature DB >> 22580403

The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor.

Yifan Zhan1, Yuekang Xu, Andrew M Lew.   

Abstract

Granulocyte-macrophage colony stimulating factor (GM-CSF) is a cytokine that functions as a hematopoietic growth factor for the generation of white blood cells and is used clinically to stimulate hematopoiesis following chemotherapy. Apart from stimulating production of granulocytes and monocytes/macrophages, GM-CSF has also long been used for in vitro survival/generation of dendritic cells (DCs) from monocytes and bone marrow cells. Evidence has emerged pointing to an additional role for GM-CSF in regulating the function and differential development of several DC subsets. These newly ascribed functions of GM-CSF may underscore its importance in immunity against pathogens as well as initiating/mediating immunopathology in chronic inflammation. Here we summarize recent advances on the role of GM-CSF in regulating the development and function of DC subsets and discuss the biological significance of these new findings.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580403     DOI: 10.1016/j.molimm.2012.04.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  34 in total

Review 1.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 2.  Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage.

Authors:  Irina Ushach; Albert Zlotnik
Journal:  J Leukoc Biol       Date:  2016-06-28       Impact factor: 4.962

3.  Effect of apoptotic cell recognition on macrophage polarization and mycobacterial persistence.

Authors:  Tatiana de Oliveira Fulco; Priscila Ribeiro Andrade; Mayara Garcia de Mattos Barbosa; Thiago Gomes Toledo Pinto; Paula Fernandez Ferreira; Helen Ferreira; José Augusto da Costa Nery; Suzana Côrte Real; Valéria Matos Borges; Milton Ozório Moraes; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio; Roberta Olmo Pinheiro
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

Review 4.  Cell-based immunotherapy against gliomas: from bench to bedside.

Authors:  M Sarah S Bovenberg; M Hannah Degeling; Bakhos A Tannous
Journal:  Mol Ther       Date:  2013-05-07       Impact factor: 11.454

5.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

6.  Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization.

Authors:  Kathryn A Patras; Nai-Yu Wang; Erin M Fletcher; Courtney K Cavaco; Alyssa Jimenez; Mansi Garg; Joshua Fierer; Tamsin R Sheen; Lakshmi Rajagopal; Kelly S Doran
Journal:  Cell Microbiol       Date:  2013-01-30       Impact factor: 3.715

7.  Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.

Authors:  Xianzheng Wang; Aihua Dong; Jingjing Xiao; Xingjun Zhou; Haili Mi; Hanqian Xu; Jiming Zhang; Bin Wang
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

8.  Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy.

Authors:  Peter B Rogers; Elizabeth Hiltbold Schwartz
Journal:  J Vis Exp       Date:  2018-08-10       Impact factor: 1.355

Review 9.  Targeting GM-CSF in inflammatory diseases.

Authors:  Ian P Wicks; Andrew W Roberts
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

Review 10.  An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.

Authors:  David A Reardon; Kai W Wucherpfennig; Gordon Freeman; Catherine J Wu; E Antonio Chiocca; Patrick Y Wen; William T Curry; Duane A Mitchell; Peter E Fecci; John H Sampson; Glenn Dranoff
Journal:  Expert Rev Vaccines       Date:  2013-06       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.